When
Eli Lilly
reports first-quarter earnings on Thursday morning, one drug will be on everyone’s minds: Mounjaro.
Excitement over the diabetes and obesity treatment has driven shares of Lilly up massively. The stock has soared 32% over the past 12 months, and is up about 3% so far this year. It trades at 41 times earnings expected over the next 12 months, according to FactSet.
Costco is known for selling daily necessities in big packages, from toilet paper to coffee. But now it's edging into...
Money is going into retirement savings401(k) contribution limits should continue their upward climb in 2024, according to a recent projection...
Here's How Much JPMorgan Says You Can Pull From Your Retirement Accounts YearlyJPMorgan Chase says ongoing inflation and an outlook...
The September sell-off in Dow Jones and S&P 500 stocks is getting so intense, some wonder if it's already overdone....
